Compare LUNG & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | AUBN |
|---|---|---|
| Founded | 1995 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 88.8M |
| IPO Year | 2020 | 1996 |
| Metric | LUNG | AUBN |
|---|---|---|
| Price | $2.31 | $26.13 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 844.0K | 853.0 |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | 7.64 | ★ 13.66 |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $90,497,000.00 | $619,000.00 |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | ★ N/A | $20.36 |
| Revenue Growth | ★ 8.01 | 0.81 |
| 52 Week Low | $1.13 | $21.60 |
| 52 Week High | $2.89 | $28.88 |
| Indicator | LUNG | AUBN |
|---|---|---|
| Relative Strength Index (RSI) | 65.52 | 49.41 |
| Support Level | $2.16 | $25.09 |
| Resistance Level | $2.39 | $26.58 |
| Average True Range (ATR) | 0.24 | 0.23 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 79.49 | 38.84 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.